# Gilead Sciences Inc (NASDAQ: GILD), San Dimas, CA – FDA Inspections

Source: https://www.keypedia.com/companies/gilead-sciences-inc/25d591ee-1217-4ca3-9134-ed69477f677f

> Inspection records and compliance data for Gilead Sciences Inc in San Dimas, California. 7 FDA inspections on record (1 OAI), last inspected April 26, 2018. Publicly traded as NASDAQ: GILD.

---

## Details

- Name: Gilead Sciences Inc
- FEI Number: 2082946
- Facility Type: Sterile Drug Manufacturer
- Address Line 1: 650 Cliffside Dr
- City: San Dimas
- State: California
- Zip Code: 91773
- Country Name: United States
- Address: 650 Cliffside Dr, San Dimas, California 91773, United States
- Country: United States

## Stock

- Stock ticker: GILD
- Exchange: NASDAQ
- Share price: $167.95
- Market cap: $208.3B
- Price as of: November 13, 2026

## Related Documents

- FDA Inspection 1057465 - Gilead Sciences Inc - 2018-04-26 — classification: No Action Indicated (NAI), source: FDA, date: April 26, 2018
- FDA Inspection 986126 - Gilead Sciences Inc - 2016-01-19 — classification: No Action Indicated (NAI), source: FDA, date: January 19, 2016
- [FDA Inspection 880678 - Gilead Sciences Inc - 2014-05-16](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/1d17f9d0-d4be-4888-bf34-c48d33765136) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 16, 2014
- FDA Inspection 846107 - Gilead Sciences Inc - 2013-08-07 — classification: No Action Indicated (NAI), source: FDA, date: August 7, 2013
- FDA Inspection 793344 - Gilead Sciences Inc - 2012-08-03 — classification: No Action Indicated (NAI), source: FDA, date: August 3, 2012
- FDA Inspection 701937 - Gilead Sciences Inc - 2010-12-07 — classification: No Action Indicated (NAI), source: FDA, date: December 7, 2010
- [483 - Gilead Sciences Inc - 2010-02-12](https://www.keypedia.com/records/483/gilead-sciences-inc/5cec8b9b-bf8c-46d3-877a-4e521fa22a0e) — source: FDA, date: February 12, 2010
- [FDA Inspection 645091 - Gilead Sciences Inc - 2010-02-12](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/f55d2bcb-9a86-45bf-a996-db76337076ed) — classification: Official Action Indicated (OAI), source: FDA, date: February 12, 2010

## Related Companies

- [Appco Pharma, LLC](https://www.keypedia.com/companies/appco-pharma-llc/63262db1-9074-411f-915f-f0b3e49884b8)
- [Hercon Pharmaceuticals, LLC](https://www.keypedia.com/companies/hercon-pharmaceuticals-llc/fec71b58-f9ca-4d72-a14a-c02da0a17760)
- [PAI Holdings, LLC, dba Pharmaceutical Associates, Inc](https://www.keypedia.com/companies/pai-holdings-llc-dba-pharmaceutical-associates-inc/8c0bd848-8106-4ffb-9eac-4202f50a39ab)
- [Bristol-Myers Squibb Company](https://www.keypedia.com/companies/bristol-myers-squibb-company/f88df458-d615-433c-956b-d484506e4986)
- [BioTel Research, LLC](https://www.keypedia.com/companies/biotel-research-llc/2a9f13e0-a9ee-4e1b-a154-2190996d80db)
- [Pfizer Inc.](https://www.keypedia.com/companies/pfizer-inc/95f0f34c-638b-4a6b-8c65-35fb37711e6b)
- [Torrent Pharmaceuticals Limited](https://www.keypedia.com/companies/torrent-pharmaceuticals-limited/3132b954-14e5-4ee9-bf30-7ae06ff6899e)
- [AltaSciences Clinical Los Angeles Inc.](https://www.keypedia.com/companies/altasciences-clinical-los-angeles-inc/977107a9-0682-40d1-b775-8c0cb8c7e822)
- [David L. Wirta, M.D.](https://www.keypedia.com/companies/david-l-wirta-md/f239b2b9-d44b-4aa0-b2e3-3506e3831bae)
- [Bausch Health Americas, Inc.](https://www.keypedia.com/companies/bausch-health-americas-inc/46368cf4-fd1b-4ed0-a010-ae5ccd022cb6)

## Related Officers

- [Senior Consumer Safety Officer](https://www.keypedia.com/people/carla-j-lundi/a10ed698-54fe-4635-a766-8c31f501dfb2)
